Aptevo Therapeutics Inc.
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 16.66% | -79.13% | -48.45% | -59.43% | -61.60% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 99.12% | 18.98% | 14.66% | 19.60% | -12.31% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -88.53% | -82.63% | -62.84% | -3.85% | -6.41% |
Total Current Assets | 15.68% | -70.13% | -44.09% | -52.61% | -57.76% |
|
|||||
Total Current Assets | 15.68% | -70.13% | -44.09% | -52.61% | -57.76% |
Net Property, Plant & Equipment | -14.96% | -14.76% | -14.61% | -14.48% | -14.28% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 4.71% | -52.68% | -37.24% | -44.17% | -48.39% |
|
|||||
Total Accounts Payable | -22.30% | 1.85% | -23.37% | -11.70% | -23.33% |
Total Accrued Expenses | 16.59% | -70.68% | -11.53% | -39.54% | -30.96% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 941.76% | 322.39% | -53.68% | -44.47% | -87.80% |
Total Other Current Liabilities | 941.76% | 322.39% | -53.68% | -44.47% | -87.80% |
Total Current Liabilities | -9.74% | -14.37% | -14.08% | -13.96% | -21.59% |
|
|||||
Total Current Liabilities | -9.74% | -14.37% | -14.08% | -13.96% | -21.59% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -16.24% | -15.19% | -14.23% | -13.36% | -12.58% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -12.99% | -14.84% | -14.14% | -13.58% | -17.39% |
|
|||||
Common Stock & APIC | 10.84% | 6.82% | 7.07% | 5.78% | 5.79% |
Retained Earnings | -10.17% | -10.29% | -10.80% | -10.90% | -11.81% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 46.18% | -124.14% | -61.09% | -69.97% | -72.54% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 46.18% | -124.14% | -61.09% | -69.97% | -72.54% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 46.18% | -124.14% | -61.09% | -69.97% | -72.54% |
|